Type 1 diabetes is a life-changing artificial pancreas that can eliminate the need for finger-prick tests and prevent life-threatening hypoglycaemic attacks, where blood sugar levels fall too low.
This technology’s potential is that nearly 900 patients with type 1 diabetes in England are testing a potentially life-changing artificial pancreas that can eliminate the need for finger-prick tests and prevent life-threatening hypoglycaemic attacks where blood sugar levels fall too low.
The hybrid closed-loop system uses a sensor under the skin. It continually monitors the levels, and a pump automatically adjusts the amount of insulin required. 6-year-old Charlotte, from Lancashire, is one of many tiny creatures using it. Her mother, Ange Abbott, told us it has significantly impacted the whole family.”She said, “If you have had an effect like this before, your battle isn’t over.”
Four hundred thousand people in the UK have type 1 diabetes, where the body can’t produce insulin. NHS England says it is the first nationwide test of the technology globally, and it comes 100 years after the first diabetes patient received insulin injections. The hybrid system is not entirely automated because the number of carbohydrates eaten at mealtimes needs to be inputted.
“It’s exciting to be able to improve the quality of life for Charlotte. She used to have a lot of his blood glucose readings within that target range, but with our new artificial pancreas, she can now go back to being type 1 without any problems.
“This sentence, from Yasmin Hopkins, tells the story of a woman who has received an artificial Pancreas as part of the pilot. It shows that the benefits of using artificial intelligence are not only significant in terms of liveliness and overall quality of life but also in terms-concerning Tau numbing properties and pendulous qualities- which are currently unknown.
This sentence, from Yasmin Hopkins, tells the story of a woman who has received Artificial Intelligence as part of the pilot. It shows benefits associated with using an AI when living a whole and healthy life – including less stress and napping!
Yasmin said that she feels “liberated” by the new technology because it no longer takes away from her time worries. “Before, I would wake up and feel like I had risks in my rearview mirror,” she said. “Now, I don’t have any concerns about my long-term complications.”
Diabetes patients have a range of interests and concerns with having machines monitor and deliver medication to them. For example, if blood sugar levels are not kept under control, diabetes patients could risk long-term damage to their heart, kidneys, eyes, and nerves.
Type 1 diabetes is not far away from the holy grail of a fully automated system. People with type 1 diabetes can get on with their lives without worrying about glucose levels or medication.
Chris Askew, chief executive of Diabetes UK, said: “This technology can transform the lives of people with type 1 diabetes, improving both their quality of life and clinical outcomes.”
Eight hundred seventy-five patients have joined the pilot, which will enroll up to 1,000 people. The results will be part of an assessment by the National Institute for Health and Care Excellence, which considers where to roll out the technology more widely.